The Australian biotech sector is at an “inflection point” and is ready to work with the federal government on its Future Made in Australia plan, and other critical policies,...
More than a decade after its introduction, the research and development tax incentive has been “life-changing” for Australia’s biotech industry and an example of how effective long-term consistent policy...
Helping companies see the benefit of being commonly understood is the essence of ensuring a comparable environmental, social and governance (ESG) practice for biotechs and medtechs. This provided the...
